Longboard Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Longboard Pharmaceuticals

11/05/2021 04:17

* Longboard Pharmaceuticals Inc  LBPH.OQ  reported a quarterly
adjusted loss of 84 cents​​ per share for the quarter ended
in March. The mean expectation of two analysts for the quarter
was for a loss of 94 cents per share.
* Revenue was $0.00​​;  analysts expected $0.00.
* Longboard Pharmaceuticals Inc's reported EPS for the quarter
was a loss of 84 cents​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Longboard Pharmaceuticals Inc shares had fallen by 39.1% this
quarter.
* The company reported a quarterly loss of $5.7 million.
* Wall Street's median 12-month price target for Longboard
Pharmaceuticals Inc is $33.50 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 11 at 03:17 a.m. GMT.
​All figures in $